StockData
Sight Sciences, Inc. logo

Sight Sciences, Inc. (SGHT) stock

SGHTNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 4/30164% above fair value
$10.49−0.10 (-0.94%)

Close on Nov 17, 2026Market cap $577.87MP/E –Yield –

Sight Sciences ebitda

EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.

Sight Sciences's ebitda for the twelve months ending Jun 30, 2026 was -$27.47M. For fiscal 2025 it was -$36.61M.

Annual ebitda

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$36.61M–
FY2024Dec 31, 2024-$49.82M–
FY2023Dec 31, 2023-$56.66M–

Quarterly ebitda

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026-$3.79M–
Q1 FY2026Mar 31, 2026-$12.31M–
Q4 FY2025Dec 31, 2025-$3.56M–
Q3 FY2025Sep 30, 2025-$7.80M–
Q2 FY2025Jun 30, 2025-$11.54M–
Q1 FY2025Mar 31, 2025-$13.71M–
Q4 FY2024Dec 31, 2024-$11.75M–
Q3 FY2024Sep 30, 2024-$11.07M–
Q2 FY2024Jun 30, 2024-$12.47M–
Q1 FY2024Mar 31, 2024-$14.53M–
Q4 FY2023Dec 31, 2023-$10.95M–
Q3 FY2023Sep 30, 2023-$13.25M–
Q2 FY2023Jun 30, 2023-$15.04M–
Q1 FY2023Mar 31, 2023-$17.42M–

More Sight Sciences figures

See a number that looks wrong?